Offices:
Helsinki
Investors:
we tracked 2 investors
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Total investments received (USD) - we tracked 2 transactions
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
TILT Biotherapeutics Ltd is a preclinical stage company working in the field of cancer immunotherapy. TILT aims to translate its unique approach into clinical trials.
The company’s patented technology involves utilization of oncolytic viruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR) and checkpoint inhibiting antibody therapy.
The TILT approach has the potential to achieve similar results in CAR therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Companies with similar profile to TILT Biotherapeutics:
| Company | Criteria |
|---|
 Synoste Oy55% | - Similar verticals: Health services
- Similar business models: B2B
- At least one vc investor: Lifeline Ventures
- At least one other investor: Business Finland
- Total raised in a similar range: 10M+ USD
|
| Oura Health 55% | - Similar verticals: Health services
- Similar business models: B2B
- At least one vc investor: Lifeline Ventures
- At least one other investor: Business Finland
- Total raised in a similar range: 10M+ USD
|
| Valkee 45% | - Similar verticals: Health services
- Similar business models: B2B
- At least one vc investor: Lifeline Ventures
- Total raised in a similar range: 10M+ USD
|
 Draupnir Bio44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| NMD Pharma 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
 Aprea Therapeutics44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
 Sanifit Therapeutics44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
 Alvotech44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| Galecto Biotech 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| STipe Therapeutics 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| Cinclus Pharma 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| Cavidi 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| Varjo 44% | - Similar business models: B2B
- At least one vc investor: Lifeline Ventures
- At least one other investor: Business Finland
- Total raised in a similar range: 10M+ USD
|
| Iceye 44% | - Similar business models: B2B
- At least one vc investor: Lifeline Ventures
- At least one other investor: Business Finland
- Total raised in a similar range: 10M+ USD
|
| Nanoform Finland 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| Norsepower 44% | - Similar business models: B2B
- At least one vc investor: Lifeline Ventures
- At least one other investor: Business Finland
- Total raised in a similar range: 10M+ USD
|
| AFYX Therapeutics 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| BoneSupport 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| Mobidiag 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| Unibio 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
